ArticleSurgical case reports2025
Bronchopleural Fistula Following Lobectomy after Prior Thoracic Endovascular Aortic Repair: A Case Report.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical benefits of covering the bronchial stump with a free pericardial fat pad after thoracoscopic lobectomy.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBronchopleural fistula (BPF) is a severe complication of lung cancer surgery that is often associated with impaired blood supply and poor healing. Thoracic aortic aneurysms (TAA) frequently coexist with lung cancer owing to their shared risk factors, and thoracic endovascular aortic repair (TEVAR) may further increase the risk of BPF by compromising bronchial artery blood flow. CASE PRESENTATION: A 72-year-old male with a history of cerebral infarction, hypertension, and a 4.8 cm TAA was incidentally found to have a 1.4 cm pulmonary nodule in the right lower lobe. Staged treatment was planned using TEVAR, followed by right lower lobectomy. TEVAR was performed successfully, and 48 days later, lobectomy confirmed stage IB large-cell carcinoma. On POD 27, the patient developed fever and dyspnea. CT revealed BPF, which was likely due to reduced bronchial blood flow after TEVAR. Chest tube drainage and an open-window thoracostomy were performed. Eight months later, thoracoplasty was performed using a muscle flap and omentopexy. The patient recovered completely and remained recurrence-free for 2 years.
conclusionsThis case underscores the importance of careful planning and surgical strategies to prevent BPF in patients with concomitant lung cancer and TAA. Early recognition of risk factors, including TEVAR-related bronchial ischemia, is crucial for optimizing outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.